Literature DB >> 17592782

Does state certification or licensure influence outpatient substance abuse treatment program practices?

Jamie F Chriqui1, Yvonne Terry-McElrath, Duane C McBride, Shelby Smith Eidson, Curtis J VanderWaal.   

Abstract

In the United States, state governments legally authorize outpatient substance abuse treatment programs. In some states, programs are certified or accredited (ideal standards). Other states license programs (minimal standards). Additionally, some states authorize programs through "deemed status", which is afforded to programs attaining accreditation from a national accrediting body. Primary legal research and the National Survey of Substance Abuse Treatment Services' (N-SSATS) data were used to examine the relationships between state authorization type (certification/accreditation vs licensure with and without deemed status) and outpatient treatment program practices. Programs in certification/accreditation (vs licensure) states had significantly higher odds of offering wrap-around and continuing care/after care services associated with better long-term treatment outcome. Programs in states that allowed for certification/accreditation with deemed status had significantly lower odds of infectious disease testing, but higher odds of providing group and family counseling. Results suggest that state authorization type may impact services offered by outpatient treatment programs.

Entities:  

Mesh:

Year:  2007        PMID: 17592782     DOI: 10.1007/s11414-007-9069-z

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  21 in total

1.  On-site primary care and mental health services in outpatient drug abuse treatment units.

Authors:  P D Friedmann; J A Alexander; L Jin; T A D'Aunno
Journal:  J Behav Health Serv Res       Date:  1999-02       Impact factor: 1.505

2.  Professionalism, regulation, and the market: impact on accountability for quality of care.

Authors:  L Gregory Pawlson; Margaret E O'Kane
Journal:  Health Aff (Millwood)       Date:  2002 May-Jun       Impact factor: 6.301

3.  Health care in the 2004 presidential election.

Authors:  Robert J Blendon; Drew E Altman; John M Benson; Mollyann Brodie
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

4.  A structural model of the substance use pathways among minority youth.

Authors:  Min Qi Wang; Resa F Matthew; Nikki Bellamy; Syretta James
Journal:  Am J Health Behav       Date:  2005 Nov-Dec

Review 5.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

6.  Mandatory reporting of infectious diseases by clinicians.

Authors:  T L Chorba; R L Berkelman; S K Safford; N P Gibbs; H F Hull
Journal:  JAMA       Date:  1989-12-01       Impact factor: 56.272

7.  An organizational analysis of service patterns in outpatient drug abuse treatment units.

Authors:  T D'Aunno; T E Vaughn
Journal:  J Subst Abuse       Date:  1995

Review 8.  Between despair and hope: health services research on treatment of alcohol abuse.

Authors:  D McCarty
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

9.  Organizational correlates of access to primary care and mental health services in drug abuse treatment units.

Authors:  P D Friedmann; J A Alexander; T A D'Aunno
Journal:  J Subst Abuse Treat       Date:  1999-01

10.  Ownership and performance of outpatient substance abuse treatment centers.

Authors:  J R Wheeler; H Fadel; T A D'Aunno
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

View more
  13 in total

1.  Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs.

Authors:  Yvonne M Terry-McElrath; Jamie F Chriqui; Duane C McBride
Journal:  Health Serv Res       Date:  2010-11-24       Impact factor: 3.402

2.  A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.

Authors:  Traci R Rieckmann; Anne E Kovas; Bentson H McFarland; Amanda J Abraham
Journal:  J Subst Abuse Treat       Date:  2011-08-06

3.  Community context and healthcare quality: the impact of community resources on licensing and accreditation of substance abuse treatment agencies.

Authors:  Matthew E Archibald; Caddie Putnam Rankin
Journal:  J Behav Health Serv Res       Date:  2013-10       Impact factor: 1.505

4.  Legislating clinical practice: counselor responses to an evidence-based practice mandate.

Authors:  Traci Rieckmann; Luke Bergmann; Caitlin Rasplica
Journal:  J Psychoactive Drugs       Date:  2011-09

5.  Availability of HIV-related health services in adolescent substance abuse treatment programs.

Authors:  H K Knudsen; C B Oser
Journal:  AIDS Care       Date:  2009-10

6.  Employing policy and purchasing levers to increase the use of evidence-based practices in community-based substance abuse treatment settings: reports from single state authorities.

Authors:  Traci R Rieckmann; Anne E Kovas; Elaine F Cassidy; Dennis McCarty
Journal:  Eval Program Plann       Date:  2011-03-02

7.  Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities.

Authors:  Traci Rieckmann; Anne E Kovas; Beth A Rutkowski
Journal:  J Psychoactive Drugs       Date:  2010-09

8.  Associations among state and local organizational contexts: Use of evidence-based practices in the criminal justice system.

Authors:  Craig E Henderson; Douglas W Young; Jill Farrell; Faye S Taxman
Journal:  Drug Alcohol Depend       Date:  2009-01-25       Impact factor: 4.492

9.  Adoption of injectable naltrexone in U.S. substance use disorder treatment programs.

Authors:  Lydia Aletraris; Mary Bond Edmond; Paul M Roman
Journal:  J Stud Alcohol Drugs       Date:  2015-01       Impact factor: 2.582

10.  Filling service gaps: Providing intensive treatment services for offenders.

Authors:  Douglas W Young; Jill L Farrell; Craig E Henderson; Faye S Taxman
Journal:  Drug Alcohol Depend       Date:  2009-03-03       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.